Bio Matters: Oklahoma's Altheus Theraputics reaches Phase 2 trial for drug therapy
Local firm finds adequate investment capital to reach key milestone in company's development.Published: Sunday, January 5, 2014 By: Jim Stafford Source: The Oklahoman
There is a pioneering quality to Oklahoma City-based Altheus Therapeutics and the milestones the company has achieved in advancing a new drug therapy for a painful condition known as inflammatory bowel disease.
In June 2012, Altheus became the first Oklahoma-based company to launch a Phase 2 trial of a medical drug developed in the Sooner State
The Altheus formulation was conceived by Dr. Richard Harty, a scientist who studied inflammatory bowel disease for more than three decades, including 14 years as chief of gastroenterology and digestive disease at the University of Oklahoma Health Sciences Center.